Over the past few years — and most visibly since the war in Ukraine — something fundamental has changed in how money functions at the…

🚀 360DISRUPTION.COM Africa doesn’t need more promises.It needs builders.At 360Disruption, we focus on execution-led foreign direct investment that creates local jobs, manufacturing, and national capability — especially in health and diagnostics. This isn’t aid.And it isn’t consulting.It’s execution that leaves something behind. 🧠 Who We Are Founded and led by Anjo De Heus, a USA-based entrepreneur, strategist, and ecosystem builder, 360Disruption bridges innovation and capital between the United States, the Gulf region and #Africa. We’re more than a consultancy — We’re a movement. A mindset. A catalyst for unstoppable transformation. At 360Disruption, we exist to challenge convention, shatter limitations, and unlock market potential that others can’t even see. “The future belongs to those who disrupt, not those who adapt.” We don't follow market shifts — we cause them. 🚀 What We Do We partner with visionary founders, free zones, investors, and global innovators to drive strategic disruption across industries, with a strong focus on Health-Tech, Bio-Tech, and Healthcare. 🔥 Our Focus Areas Unconventional Strategy Growth Acceleration Disruptive Go-to-Market Strategic Investment Bridges 🌍 Learn more: https://360disruption.com Subscribe to stay up to date. https://www.youtube.com/channel/UCalFhO_HG20aWTNBPs6A2Rg/?sub_confirmation=1

360Disruption is an official Channel Partner of Ajman Free Zone Authority – one of the UAE’s most dynamic and accessible free zones. This strategic partnership opens a powerful new chapter for our platform, and more importantly, for the U.S. healthtech and biotech innovators we work with. ✅ Why This Matters Ajman Free Zone (AFZ) is fast becoming a preferred launchpad for next-gen companies…

Most Early-Stage Biotech Playbooks make one point crystal clear: science alone isn’t enough. Early-stage biotech ventures must be execution-first, ecosystem-aware, and expansion-ready — especially when scaling across borders. At 360Disruption, we didn’t need a playbook to realize this — we built our entire platform on it. Whether enabling vaccine localization with Verndari, launching a sleep diagnostics JV with Pioneer Diagnostics, or onboarding breakthrough…

Most Early-Stage Biotech Playbooks make one point crystal clear: science alone isn’t enough. Early-stage biotech ventures must be execution-first, ecosystem-aware, and expansion-ready — especially when scaling across borders. At 360Disruption, we didn’t need a playbook to realize this — we built our entire platform on it. Whether enabling vaccine localization with Verndari, launching a sleep diagnostics JV with Pioneer Diagnostics, or onboarding breakthrough…

The Quiet Power Behind Market Disruption: Why Board-Level Advisory Can Make or Break Your Commercial Success Reality Check: Most startups think their biggest hurdle is funding. But in reality, it’s commercial clarity — the ability to turn vision into traction, in the real world, with real markets. That’s where board-level advisory becomes not just helpful — but essential. Thesis: At 360Disruption, we don’t just build go-to-market strategies.

Strategic Execution in Action: Why Health Innovators Choose 360Disruption In today’s crowded health innovation landscape, it’s not enough to have breakthrough science — you need a commercialization and strategic engine that understands the complexity of scaling in real-world markets. That’s where 360Disruption comes in. We are not consultants.We are strategic partners who incubate, accelerate, and commercialize.

Strategic Execution in Action: Why Health Innovators Choose 360Disruption In today’s crowded health innovation landscape, it’s not enough to have breakthrough science — you need a commercialization and strategic engine that understands the complexity of scaling in real-world markets. That’s where 360Disruption comes in. We are not consultants.We are strategic partners who incubate, accelerate, and commercialize.

Strategic Execution in Action: Why Health Innovators Choose 360Disruption In today’s crowded health innovation landscape, it’s not enough to have breakthrough science — you need a commercialization and strategic engine that understands the complexity of scaling in real-world markets. That’s where 360Disruption comes in. We are not consultants.We are strategic partners who incubate, accelerate, and commercialize.

🔓 Unlocking Health Innovation: Why the Future of Wellness in the Gulf Runs Through the 360 Ecosystem In a rapidly evolving world where health is no longer a reactive industry but a proactive movement, one platform is quietly reshaping how innovation reaches real people: 360Disruption. What began as a strategic bridge between North American health-tech and the Gulf region has now grown into a…

360Disruption: Building Ventures, Boosting Nations In an era where innovation is often reduced to buzzwords and superficial metrics, 360Disruption dares to do the real work — venture building from the ground up. Headquartered in the UAE and deeply rooted in the Gulf region’s ambitions, we don’t just scout innovation — we incubate it, accelerate it, and commercialize it with purpose. Our mission: to transform promising health-tech from North America into impactful, regionally grounded enterprises that serve patients, create jobs, and generate value for the Emirates.

Launching a Healthtech Venture in the UAE: A Strategic Guide by 360Disruption The United Arab Emirates (UAE) is quickly becoming one of the most promising launchpads for global healthtech innovation. With forward-thinking leadership, robust infrastructure, and a commitment to becoming a regional healthcare powerhouse, the UAE offers unparalleled opportunities for startups and scale-ups alike. At 360Disruption, we’ve helped companies from the U.S.

Why the UAE’s Medical Device Classification System is a Game-Changer for U.S. Healthtech Companies The United Arab Emirates (UAE) has quietly built one of the world’s most innovation-friendly pathways for medical device companies—and now, more than ever, U.S.-based healthtech startups and scaleups should take notice. Unlike the FDA’s formal and risk-heavy classification system, the UAE’s Ministry of Health and Prevention (MOHAP) offers a flexible, product-specific, and internationally harmonized framework that accelerates market access, reduces cost, and creates entry into a health-conscious, tech-forward region.

Why 360Disruption Is the Partner of Choice for Health-tech Expansion in the Gulf In today’s competitive global health-tech landscape, entering new markets requires more than a regulatory checklist or a polished investor deck. It requires local traction, commercial validation, and trusted partnerships that can turn plans into performance. That’s where 360Disruption comes in. At 360Disruption, we don’t offer advisory in a vacuum.

Evolution of Healthtech Startups in Dubai: From Foundation to Global Future Dubai has rapidly emerged as a powerhouse for healthtech innovation. What began as a vision to digitize and modernize healthcare has evolved into a vibrant ecosystem that fuses government backing, private sector momentum, and emerging technology to redefine how healthcare is delivered and experienced. A Timeline of Growth: From Infrastructure to Intelligence…

Beyond the License: How Foreign Healthtech Innovators Can Truly Land in the UAE Dubai is making headlines as a rising health-tech powerhouse — and for good reason. With over $2 billion invested in AI applications across the healthcare sector, and government initiatives like Dubai Health Strategy 2030 and the Dubai Future Foundation leading the charge, the city is fast becoming a magnet for digital health, med-tech, and wellness innovation.

Make It in the Emirates: The Smart Way for foreign Founders to Land Why the UAE is the Gulf's most effective launchpad for innovation, and how to do it right. The Narrative Is Real The phrase "Make It in the Emirates" isn't just branding — it's a signal. The UAE has invested billions into making itself the ideal entry point for global innovators.

Go-to-Market ≠ Growth Strategy: Why the Gulf Demands Both The final GTM trap U.S. companies fall into — and how to scale sustainably in the Gulf once you've landed. Landing Isn’t Scaling A lot of U.S. startups do the hard work: they localize, set up in the right free zone, validate market fit, build partnerships — and then stall. Why?

From Delaware to Dubai: A Practical Roadmap for U.S. Startups Entering the Gulf How to go from idea to traction across the UAE and Gulf region — the right way. It Starts with Intent You’re a U.S.-based founder or exec. You’ve got a product with potential. And you’re hearing it more and more: "You should be in the Gulf. The opportunity is huge."